Dr. De Cara’s recent research interests focus on identifying patients at risk for cardiovascular complications related to cancer therapeutics by using cardiac imaging techniques and examining clinical characteristics associated with increased cardiovascular risk.
Risk factors associated with high probability of pulmonary hypertension in patients with myeloproliferative neoplasms.
Risk factors associated with high probability of pulmonary hypertension in patients with myeloproliferative neoplasms. Int J Hematol. 2026 Jul 21.
PMID: 42481866
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study.
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study. JACC Adv. 2026 Jun; 5(6 Pt 2):102821.
PMID: 42312783
Outcomes and Safety of CAR-T Cell Therapy in B-NHL Patients With Reduced Left Ventricular Ejection Fraction.
Outcomes and Safety of CAR-T Cell Therapy in B-NHL Patients With Reduced Left Ventricular Ejection Fraction. Transplant Cell Ther. 2026 May 29.
PMID: 42217793
Low serum cholesterol is a biomarker of advanced disease and poor outcomes in myeloproliferative neoplasms.
Low serum cholesterol is a biomarker of advanced disease and poor outcomes in myeloproliferative neoplasms. Blood Adv. 2026 05 26; 10(10):3746-3755.
PMID: 41779966
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosis.
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosis. Cardiooncology. 2026 Mar 11; 12(1).
PMID: 41814386
Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms.
Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms. Blood Adv. 2026 Mar 10; 10(5):1603-1613.
PMID: 41499780
Ruxolitinib and heart failure outcomes among patients with myelofibrosis.
Ruxolitinib and heart failure outcomes among patients with myelofibrosis. Leuk Lymphoma. 2026 May; 67(6):1335-1342.
PMID: 41784313
Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other.
Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other. Future Cardiol. 2025 12; 21(12):1165-1175.
PMID: 41292504
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025 Aug; 7(5):538-553.
PMID: 40668166
Echocardiographic Detection of Regional Wall Motion Abnormalities Using Artificial Intelligence Compared to Human Readers.
Echocardiographic Detection of Regional Wall Motion Abnormalities Using Artificial Intelligence Compared to Human Readers. J Am Soc Echocardiogr. 2024 07; 37(7):655-663.
PMID: 38556038